Weiyan Xie

629 total citations
31 papers, 384 citations indexed

About

Weiyan Xie is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics. According to data from OpenAlex, Weiyan Xie has authored 31 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Molecular Biology and 10 papers in Genetics. Recurrent topics in Weiyan Xie's work include Pituitary Gland Disorders and Treatments (20 papers), Glioma Diagnosis and Treatment (10 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Weiyan Xie is often cited by papers focused on Pituitary Gland Disorders and Treatments (20 papers), Glioma Diagnosis and Treatment (10 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Weiyan Xie collaborates with scholars based in China, United States and United Kingdom. Weiyan Xie's co-authors include Yazhuo Zhang, Chuzhong Li, Jing Guo, Qiuyue Fang, Yafang Li, Yun Wang, Yi He, Kai Kang, Sen Cheng and Yanrui Yang and has published in prestigious journals such as Nature Communications, Journal of Neuroscience and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Weiyan Xie

29 papers receiving 383 citations

Peers

Weiyan Xie

EDM

CMN

GENET

Clifton G. Fulmer United States

Gerard T. Redpath United States

Terra J. Frederick United States

Catherine Vaurs‐Barrière France

Jialong Liang China

Leslie A. Kirby United States

Melanie Allen United States

Sabrina Paratore Italy

Yvan Nicaise France

Baoyan Fan United States

Clifton G. Fulmer United States

Weiyan Xie

142 ×0.7

38 ×0.3

EDM

48 ×0.5

83 ×1.1

CMN

36 ×0.6

GENET

Citations per year, relative to Weiyan Xie Weiyan Xie (= 1×) peers Clifton G. Fulmer

Countries citing papers authored by Weiyan Xie

Since Specialization

Citations

This map shows the geographic impact of Weiyan Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiyan Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiyan Xie more than expected).

Fields of papers citing papers by Weiyan Xie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiyan Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiyan Xie. The network helps show where Weiyan Xie may publish in the future.

Co-authorship network of co-authors of Weiyan Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Weiyan Xie. A scholar is included among the top collaborators of Weiyan Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiyan Xie. Weiyan Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Yue, Zhao Yang, Xuejing Li, et al.. (2025). Splicing diversity enhances the molecular classification of pituitary neuroendocrine tumors. Nature Communications. 16(1). 1552–1552. 3 indexed citations

Fang, Qiuyue, et al.. (2024). Phosphorylation of PBK at Thr9 by CDK5 correlates with invasion of prolactinomas. CNS Neuroscience & Therapeutics. 30(2). e14629–e14629. 2 indexed citations

Li, Bin, Sida Zhao, Yiyuan Chen, et al.. (2024). HSPB1 promotes tumor invasion by inducing angiogenesis in PitNETs. Endocrine Related Cancer. 31(6).

Cheng, Jianhua, Weiyan Xie, Yiyuan Chen, et al.. (2024). Drug resistance mechanisms in dopamine agonist-resistant prolactin pituitary neuroendocrine tumors and exploration for new drugs. Drug Resistance Updates. 73. 101056–101056. 12 indexed citations

Xie, Weiyan, Dongfang Wang, Qiuyue Fang, et al.. (2024). Single-cell transcriptomic analysis reveals tumor cell heterogeneity and immune microenvironment features of pituitary neuroendocrine tumors. Genome Medicine. 16(1). 2–2. 15 indexed citations

Guo, Jing, Yiyuan Chen, Haibo Zhu, et al.. (2024). Three‐dimensional chromatin landscapes in somatotroph tumour. Clinical and Translational Medicine. 14(5). e1682–e1682. 1 indexed citations

Wang, Dawei, et al.. (2024). The gut microbiome in patients with Cushing’s disease affects depression- and anxiety-like behavior in mice. Microbiome. 12(1). 225–225. 1 indexed citations

Xie, Weiyan, Xiaohui Li, Caleb Chen Cao, & Nevin L. Zhang. (2023). ViT-CX: Causal Explanation of Vision Transformers. Rare & Special e-Zone (The Hong Kong University of Science and Technology). 1569–1577. 9 indexed citations

Wu, Jiangping, et al.. (2023). Identification of biomarkers associated with the invasion of nonfunctional pituitary neuroendocrine tumors based on the immune microenvironment. Frontiers in Endocrinology. 14. 1131693–1131693. 4 indexed citations

10.

Guo, Jing, Chuzhong Li, Qiuyue Fang, et al.. (2022). The SF3B1R625H mutation promotes prolactinoma tumor progression through aberrant splicing of DLG1. Journal of Experimental & Clinical Cancer Research. 41(1). 26–26. 19 indexed citations

11.

Guo, Jing, et al.. (2021). Screening and Identification of Key Microenvironment-Related Genes in Non-functioning Pituitary Adenoma. Frontiers in Genetics. 12. 627117–627117. 8 indexed citations

12.

Cheng, Sen, Jing Guo, Dawei Wang, et al.. (2021). A Novel Three-LncRNA Signature Predicting Tumor Recurrence in Nonfunctioning Pituitary Adenomas. Frontiers in Genetics. 12. 754503–754503. 7 indexed citations

13.

Chen, Yiyuan, Bin Li, Jie Feng, et al.. (2020). JAG1, Regulated by microRNA-424-3p, Involved in Tumorigenesis and Epithelial–Mesenchymal Transition of High Proliferative Potential-Pituitary Adenomas. Frontiers in Oncology. 10. 567021–567021. 12 indexed citations

14.

Cheng, Sen, Weiyan Xie, Jing Guo, et al.. (2019). Identification of key genes in invasive clinically non-functioning pituitary adenoma by integrating analysis of DNA methylation and mRNA expression profiles. Journal of Translational Medicine. 17(1). 407–407. 24 indexed citations

15.

Zhu, Haibo, Jing Guo, Weiyan Xie, et al.. (2019). The clinical characteristics and molecular mechanism of pituitary adenoma associated with meningioma. Journal of Translational Medicine. 17(1). 354–354. 9 indexed citations

16.

Yu, Guoqiang, Chuzhong Li, Weiyan Xie, et al.. (2017). Long non-coding RNA C5orf66-AS1 is downregulated in pituitary null cell adenomas and is associated with their invasiveness. Oncology Reports. 38(2). 1140–1148. 33 indexed citations

17.

Xie, Weiyan, Hongyun Wang, Yue He, et al.. (2014). CDK5 and Its Activator P35 in Normal Pituitary and in Pituitary Adenomas: Relationship to VEGF Expression. International Journal of Biological Sciences. 10(2). 192–199. 20 indexed citations

18.

Xie, Weiyan, et al.. (2012). Disruption of δ-opioid receptor phosphorylation at Threonine 161 attenuates morphine tolerance in rats with CFA-induced inflammatory hypersensitivity. Neuroscience Bulletin. 28(2). 182–192. 15 indexed citations

19.

Xie, Weiyan, Yi He, Yanrui Yang, et al.. (2009). Disruption of Cdk5-Associated Phosphorylation of Residue Threonine-161 of the δ-Opioid Receptor: Impaired Receptor Function and Attenuated Morphine Antinociceptive Tolerance. Journal of Neuroscience. 29(11). 3551–3564. 65 indexed citations

20.

He, Yi, Huili Li, Weiyan Xie, et al.. (2007). The presence of active Cdk5 associated with p35 in astrocytes and its important role in process elongation of scratched astrocyte. Glia. 55(6). 573–583. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact